Hims & Hers Health Inc
NYSE:HIMS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.22
27.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hims & Hers Health Inc
Hims & Hers Health Inc
Capital Expenditures
Hims & Hers Health Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hims & Hers Health Inc
NYSE:HIMS
|
Capital Expenditures
-$26.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Capital Expenditures
-$543.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Capital Expenditures
-$374m
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
CVS Health Corp
NYSE:CVS
|
Capital Expenditures
-$2.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Cigna Corp
NYSE:CI
|
Capital Expenditures
-$1.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Capital Expenditures
-$545m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
Hims & Hers Health Inc
Glance View
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 398 full-time employees. The company went IPO on 2019-09-09. The firm has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. The firm has partnered with dermatology experts to offer access to formulated topical creams for customers experiencing acne and signs of premature aging, such as wrinkles. The company offers telehealth solutions with combined access to a distributed provider network, digital prescriptions, cloud pharmacy, and consumer engagement strategies, all delivered through mobile and Web interfaces. The firm's Products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer.
See Also
What is Hims & Hers Health Inc's Capital Expenditures?
Capital Expenditures
-26.5m
USD
Based on the financial report for Dec 31, 2023, Hims & Hers Health Inc's Capital Expenditures amounts to -26.5m USD.
What is Hims & Hers Health Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
-266%
Over the last year, the Capital Expenditures growth was -266%.
You don't have any saved screeners yet
